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Introduction: Many factors influence late-life cognitive changes, and evaluating their joint impact is challenging.
Typical approaches focus on average decline and a small number of factors. We used multistate transition models
and index variables to look at changes in cognition in relation to frailty (accumulation of health deficits), social
vulnerability, and protective factors in the Honolulu-Asia Aging Study (HAAS).
Methods: The HAAS is a prospective cohort study of 3,845 men of Japanese descent, aged 71 to 93 years at baseline.
Cognitive function was measured using the Cognitive Abilities Screening Instrument (CASI). Baseline index variables
were constructed of health deficits (frailty), social vulnerabilities, and protective factors. The chances of improvement/
stability/decline in cognitive function and death were simultaneously estimated using multistate transition modeling
for 3- and 6-year transitions from baseline.
Results: On average, CASI scores declined by 5.3 points (standard deviation (SD) = 10.0) over 3 years and 9.5 points
(SD = 13.9) over 6 years. After adjusting for education and age, baseline frailty was associated with an increased
risk of cognitive decline at 3 years (β = 0.18, 95% confidence interval (CI), 0.08 to 0.29) and 6 years (β = 0.40, 95% CI,
0.27 to 0.54). The social vulnerability index was associated with 3-year changes (β = 0.16, 95% CI, 0.09 to 0.23) and 6-year
changes (β = 0.14, 95% CI, 0.05 to 0.24) in CASI scores. The protective index was associated with reductions in cognitive
decline over the two intervals (3-year: β = −0.16, 95% CI, −0.24 to −0.09; 6-year: β = −0.21, 95% CI, −0.31 to –0.11,).
Conclusions: Research on cognition in late life needs to consider overall health, the accumulation of protective
factors, and the dynamics of cognitive change. Index variables and multistate transition models can enhance
understanding of the multifactorial nature of late-life changes in cognition.Introduction
Although many population and longitudinal studies have
identified a range of risk factors associated with cognitive
decline, our ability to effectively treat cognitive impair-
ment remains inadequate. One challenge in unraveling
this problem is that, for any population, the cognition of
individuals does not change uniformly. Cognitive decline
occurs at different ages and at different rates of change,* Correspondence: Kenneth.Rockwood@dal.ca
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unless otherwise stated.and some individuals do not decline at all [1-4]. Cognition
in late life can also improve, as confirmed by examining
rates of “reversion” from mild cognitive impairment back
to normal cognitive states [5-11]. Even though people who
improve are at greater risk for subsequent decline [11]
some people remain in a cognitive normal state [11-13].
This variability in cognitive change appears to conform to
a stochastic process in which change in cognition is not
deterministic, but is conditional on the baseline status and
fits known probability distributions [14-16].
To address the stochastic nature of transitions in
cognition, our research group has developed a transi-
tion model based upon a parametric representation of
a multistate Poisson model [14]. This approach allowstral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and that simultaneously can incorporate the risk of death.
Multistate transition models can also be modified to in-
corporate covariates into the analysis so that the effects of
modifiers of interest can be evaluated; these have been
applied to both transitions cognitive test scores [15] and
changes in brain structure [16]. Here, our objective was to
understand how cognition changes in late life in relation
to frailty, social vulnerability, and the cumulative impact
of multiple protective factors.
Methods
Study population
We used data from the Honolulu-Asia Aging Study
(HAAS). The HAAS is a prospective cohort study of
3,845 Japanese-American men, free of dementia at base-
line. It originated in the Honolulu-Heart Program, the
participants of which were born between 1900 and 1919
and lived in Oahu, Hawaii, at baseline, as detailed else-
where [17]. In 1991, the HAAS was established to focus
on cognition and brain diseases. Follow-up examinations
took place approximately every 3 years. Clinical assess-
ments were conducted, as were structured interviews on
participant characteristics. All dates of death for HAAS
participants within the study period (1991 to 1997) were
recorded by the study’s surveillance system.
Cognitive assessments
The Cognitive Abilities Screening Instrument (CASI)
[18], a 100-point scale designed for cross-cultural use,
was administered at each study wave. It is a measure of
global cognitive function that assesses attention, con-
centration, orientation, short-term memory, long-term
memory, language abilities, visual construction, list-
generating fluency, abstraction, and judgment. The
CASI has been validated for use among Japanese and
Western populations [19] and within the items subsets
can be used to form the Hasegawa Dementia Screening
Scale, the Folstein Mini-Mental State Examination, and
the Modified Mini-Mental State Examination. The
standardized protocol used for cognitive assessments in
the HAAS has been described previously [17,20]. For
this study, two manipulations were performed to pre-
pare the CASI data for multistate transition modeling,
as has been done previously [14,15]. Individual CASI
scores were reverse scored so that lower scores repre-
sent better cognition (for example, a score of 100 on the
CASI = 0 CASI “errors”). Secondly, CASI error scores
were grouped by intervals of three (for example, 0–2
errors, 3–5 errors, and so forth) forming a series of
cognitive states ranging from high cognition/low errors
to impaired cognition/high errors. Each grouping is
considered as a global cognitive state where transition
models can be used to estimate the probabilities oftransitioning, including improvement, stability, and
decline, from baseline states to consequent cognitive
states at follow-up assessments.
Frailty index
A frailty index (FI), based on the accumulation of defi-
cits, was created using a standard procedure [21]. Vari-
ables were selected as health deficits if they were
associated with health status, accumulated with age, and
had a prevalence in the sample greater than 1% but less
than 80%. Each variable was dichotomized (0 for absent;
1 for present). These deficits were then summed and
here divided by 48, that being the total number of defi-
cits considered (see Appendix A in Additional file 1).
Thus, a participant with no missing measurements and
24 deficits would be given a FI score of 24/48 = 0.50. We
treated the FI as missing for participants in whom data
were missing on more than 20% of the items.
Social vulnerability index
Using the procedure outlined to create a FI [21], 18 social
variables were selected from the baseline wave to construct
a measure of overall social vulnerability (Social Vulnerabil-
ity Index; SVI). This approach has been demonstrated to
predict a range of health outcomes, including cognition
and survival [22,23]. All HAAS variables that could be con-
sidered as social deficits were included in a dichotomized
format (0 for absent; 1 for deficit) including living alone,
social networks, and marital status (see Appendix B in
Additional file 1). As with the FI, the social deficits were
summed and divided by the total number of health deficits
considered, producing a score between 0 and 1.
Protective factors index
To evaluate the cumulative impact of a number of pro-
tective factors, a protection index (PI) was generated
using baseline variables that were considered to be
related to positive health outcomes. A previous study
using this approach demonstrated that the aggregate
effect of protective factors can influence age-related
health outcomes [24]. Within the HAAS, 20 baseline
variables that might offer protection to age-related cog-
nitive decline were selected including physical exercise
[25,26], the use of antihypertensive medications [27],
availability of health services, not smoking cigarettes
[28], moderate alcohol consumption [29], self-rated good
health [30], healthy body weight [31], and others (see
Appendix C in Additional file 1). As with the FI and
SVI, an accumulation approach was used [21], in which
selected items were dichotomized, summed, and divided
by the total number of items considered. Note that in
this index, higher scores are positive, reflecting that
more protective factors are present (whereas in the other
two indices higher scores are negative).
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consents
Data collection was approved by the Kuakini Medical
Center Institutional Review Board, with informed consent
provided by all participants. Approval for the secondary
analyses came from the Research Ethics Committee of the
Capital District Health Authority, Halifax, Nova Scotia,
Canada.
Statistical analysis
The primary outcomes of the analyses were transitions
in cognitive status and mortality at the first and second
follow-up waves. Analyses take into consideration the
baseline state, and then estimate the probability of
transitions (staying at the same score, as well as degrees
of worsening and improvement) from each of the states
at baseline to the follow-up cognitive states using a
Poisson approximation [14,15]. The probability of death
was simultaneously modeled using a logistic function
[14,15]. The incorporation of death into the transition
models is essential, as longitudinal studies with older
subjects are inherently predisposed to attrition via death
[32], and failing to incorporate death in analyses can lead
to biased estimates [33].
For this study, the effects of the baseline level of
frailty, social vulnerability, and protective factors were
evaluated for two time intervals (3 and 6 years), control-
ling for age (in years, measured as a continuous variable,
centered on the grand mean of 78 years) and education
(measured in years, continuous, centered on the grandFigure 1 Study flowchart for two sets of models: 3-year transition mode
Abilities Screening Instrument.mean of 10.5 years). To aid in interpretation of betas (β)
and odds ratios, each of the index variables were trans-
formed by multiplying by 10 so that results relate to 10%
increases in the index variables. Figure 1 contains the
participant flow chart for the two series of models
including number of decedents within each interval. For
each interval, index variables were modeled separately
to analyze the effects of each of the indices on the
outcomes, independent of the other indices. Models
included all covariates (age, education, frailty, social
vulnerability, protective factors). The outputs of the
multivariable Poisson regression models are parameters
(β) that can be used to analyze the effects that covariates
have on the transition from any baseline state to any
follow-up cognitive state or death. A positive coefficient
indicates that increases in the predictor variable are on
average related to increases in CASI errors. When the β
coefficients are negative, the variable can be considered
to have, on average, a protective effect of changes in
cognition. As with standard regression analyses, the β
values represent the expected impact on the outcome
variable based upon a one-step increase in the predictor
variable. To ease interpretation, all coefficients from the
logistic regression models were transformed to odds
ratios; Akaike information criterion and the Bayesian
information criteria were calculated for each Poisson
model as indicators for relative quality of the model fit
(lower scores indicate better model fit). Similarly, −2log
likelihood was used for logistic regression models. All ana-
lyses were performed in SPSS 18.0 (SPSS Inc., Chicago).ls on the left; 6-year transition models on the right. CASI, Cognitive
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At baseline, the average age was 77.9 years (standard
deviation (SD) = 4.7; range 71 to 93; median = 76). The
average number of years of education was 10.5 (SD =
3.2; range 1 to 24; median = 11). Those who survived
across each of the two intervals were younger and had
slightly more education (Table 1). The average FI and
the average SVI scores at baseline were lower for survi-
vors across the two time intervals, and the average PI
was higher (Table 1). In the first interval from baseline
to wave 2, the average time between assessments was
2.9 years (SD = 0.3). Surviving men who did not have
follow-up cognitive testing were excluded (n = 700)
and 498 men had died. The three single-index models
indicated that each of the covariates had a significant
effect on cognitive transitions (Table 2), The FI and the
SVI were each associated with cognitive decline (FI:
β = 0.18, 95% confidence interval (CI), 0.08 to 0.29;
SVI: β = 0.16, 95% CI, 0.08 to 0.23), whereas the pro-
tective factors were associated with higher probability
of cognitive improvement (PI: β = −0.16, 95% CI, −0.24
to −0.09). For mortality within the first time interval,
the models indicated that education was not signifi-
cantly associated with death (P > 0.05). When all of the
covariates were entered into a multi-index model, each
continued to have an impact on cognitive transitions,
although education and social vulnerability were not
significantly associated with death (Table 3).
The second iteration of models examined the cog-
nitive transition over a longer interval, from baseline
to wave 3; the average time elapsed was 6.1 years (SD =
0.6). During this interval, 1,086 of the men had died.
Individuals who neither died within 6 years nor had
follow-up cognitive testing were excluded (n = 775).
The single index multivariate Poisson models for this
interval produced results similar to the 3-year interval,
with significant effects for each of the indices on both
cognitive transitions and death. The multi-index model
indicated that education was not significantly associ-
ated with death after accounting for the covariates






Full cohort 3,845 77.9 (4.7) 10.5 (3.2)
Alive at first follow-up 3,347 77.4 (4.4) 10.6 (3.2)
Dead at first follow-up 498 80.9 (5.4) 9.8 (3.3)
Alive at second follow-up 2,759 76.9 (4.0) 10.7 (3.2)
Dead at second follow-up 1,086 80.3 (5.3) 10.0 (3.2)
Values are shown as mean (standard deviations). CASI, Cognitive Abilities ScreeningThe β coefficients from the Poisson regression models
can be used to predict future CASI error states (fCASI):
fCASI ¼ intercept þ β baseline cognitive stateð Þ
þ β educationð Þ þ β ageð Þ þ β FIð Þ þ β SVIð Þ
þ β PIð Þ
For example, given the results of multi-index model
for the 3-year interval, an average male (78 years old
with 10.5 years of education) in CASI error group 7 at
baseline, a frailty index of 0.4, social vulnerability index
of 0.3, and a protective index of 0.2 would have the pre-
dicted transition in the following 3 years:
fCASI ¼ interceptþ β baseline cognitive stateð Þ
þβ educationð Þ þ β ageð Þ þ β FIð Þ þ β SVIð Þ
þβ PIð Þ ¼ 2:13þ 0:88 7ð Þ þ −0:085 0ð Þ
þ0:089 0ð Þ þ 0:15 4ð Þ þ 0:13 5ð Þ
þ −0:11ð Þ 2ð Þ ¼ 9:32
The zero scores for age and education are due to the
fact that these variables were centered at the cohort’s
average. For the index variables, scores are multiplied by
10 so that β represents a 10% increase in the index
scores. The model would estimate that the individual
with those characteristics would move from a CASI
error group of 7 (considered cognitively intact) to an
error group of 9, which would be associated with a CASI
score of 73. In this worked example, the model would
predict incident cognitive impairment as prior HAAS
analyses determined a CASI score <74 as an accurate
cut-point with ~80% sensitivity and 90% specificity for
identifying dementia [34].
Discussion
In this study, we examined cognitive changes in older
Japanese-American men in the HAAS in relation to
frailty and social vulnerability, and modeled the impact
of protective factors on near-term (3-year) and medium-









0.15 (0.09) 0.25 (0.13) 0.36 (0.12) 17.8 (16.4)
0.14 (0.08) 0.25 (0.13) 0.37 (0.11) 15.5 (12.5)
0.19 (0.10) 0.30 (0.15) 0.30 (0.14) 33.1 (27.7)
0.14 (0.08) 0.24 (0.12) 0.37 (0.11) 14.1 (9.9)
0.18 (0.10) 0.29 (0.0.13) 0.32 (0.13) 27.4 (24.1)
Instrument.









Wave 1 to wave 2
Intercept 1.93 (1.72, 2.14) 1.80 (1.58, 2.02) 2.81 (2.47, 3.15) 2.13 (1.72, 2.55)
Baseline cognitive state 0.90 (0.87, 0.94) 0.91(0.88, 0.95) 0.90 (0.87, 0.94) 0.88 (0.84, 0.92)
Age 0.097 (0.074, 0.12) 0.092 (0.068, 0.12) 0.10 (0.08, 0.13) 0.089 (0.065, 0.11)
Years of education −0.096 (−0.12, −0.07) −0.084 (−0.11, −0.057) −0.083 (−1.10, −0.055) −0.085 (−0.11, −0.057)
Frailty 0.184 (0.08, 0.29) 0.15 (0.052, 0.26)
Social vulnerability 0.16 (0.088, 0.23) 0.13 (0.061, 0.21)
Protective factors −0.16 (−0.24, −0.087) −0.11 (−0.19, −0.036)
Model fit statistics
BIC 11,776 12,183 11,834 11,674
AIC 11,747 12,213 11,863 11,633
Wave 1 to wave 3
Intercept 2.40 (2.12, 2.68) 2.60 (2.31, 2.88) 3.77 (3.33, 4.22) 2.95 (2.42, 3.48)
Baseline cognitive state 1.14 (1.08, 1.19) 1.14 (1.08, 1.19) 1.13 (1.08, 1.19) 1.12 (1.07, 1.18)
Age 0.19 (0.16, 0.23) 0.19 (0.16, 0.22) 0.20 (0.16, 0.23) 0.19 (0.16, 0.22)
Years of education −0.075 (−0.110, –0.039) −0.062 (−0.097, −0.027) −0.057 (−0.09, −0.021) −0.057 (−0.09, −0.021)
Frailty 0.40 (0.27, 0.54) 0.38 (0.24, 0.51)
Social vulnerability 0.14 (0.051, 0.24) 0.10 (0.01, 0.20)
Protective factors −0.21 (−0.31, −0.11) −0.19 (−0.28, −0.087)
Model fit statistics
BIC 10,560 10,881 10,620 10,534
AIC 10,533 10,853 10,593 10,496
Values are shown as β (95% confidence interval) apart from AIC (Akaike information criterion) and Bayesian information criteria (BIC).
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SVI scores) were associated with a greater risk of death,
and a greater chance of cognitive decline at 3 years. These
effects, however, were partially mitigated by a range of
health protective behaviors, even adjusting for education.
At 6 years, the results were similar in significance and dir-
ection (FI and SVI increased CASI errors, the PI decreased
errors), but were stronger. This study illustrates that the
many factors that influence cognition can be handled in a
tractable model, and illustrates the importance of consid-
ering general health status (frailty), social vulnerability,
and protective factors when examining changes in cogni-
tion in older adults.
This approach has implications for modeling the epi-
demiology of late-life cognitive decline. Particularly at a
time when new risk factors are appearing frequently
[35-37], having a means of understanding the overall
context of how risk operates in late-life disorders is im-
portant. Just as it is a tenant of everyday geriatric prac-
tice that disease presents differently in the face of frailty,
so might we expect that estimating disease risk must
also take into account the impact of multiple, interacting
medical and social problems when they are present, asthey commonly are in late life. As we develop a better
understanding of changes that occur across the lifespan
and the shared causal mechanisms in age-related dis-
eases, health researchers should rely less on traditional
statistical approaches that were designed with assump-
tions of linearity and independence. As there is a grow-
ing appreciation of a systems biology approach within
medicine and the health sciences [38-41], methods from
other scientific disciplines (for example, physics, network
science, and computer science) should be considered to
address these complexities.
PI is a relatively new approach to understanding how
the accumulation of extrinsic factors can impact health
outcomes [24]. Here, the PI was consistently associated
with positive cognitive outcomes across both time inter-
vals, even when accounting for baseline cognition, age,
education, social vulnerability, and frailty. A recent pub-
lication with a PI found that the accumulation of pro-
tective factors had a positive impact of health transitions
and mortality outcomes [24], but did not investigate the
impact on cognition. Our findings provide evidence that
the more protective factors that an individual possesses
in late life, regardless of precisely which elements are









Wave 1 to wave 2
Baseline cognitive state 1.09 (1.05,1.12) 1.10 (1.07, 1.14) 1.08 (1.05, 1.11) 1.06 (1.03, 1.10)
Age 1.09 (1.06,1.12) 1.08 (1.06, 1.11) 1.09 (1.06, 1.12) 1.08 (1.05, 1.12)
Years of education 1.02 (0.975, 1.06)* 1.04 (1.00, 1.08)* 1.03 (0.99, 1.08)* 1.03 (0.99, 1.08)*
Frailty 1.71 (1.51, 1.95) 1.71 (1.50, 1.95)
Social vulnerability 1.15 (1.06, 1.26) 1.06 (0.97, 1.17)*
Protective factors 0.77 (0.69, 0.86) 0.77 (0.68, 0.87)
Model fit statistics
−2log likelihood 1,771.41 2,000.19 1,876.42 1,732.20
Wave 1 to wave 3
Baseline cognitive state 1.09 (1.06, 1.13) 1.11 (1.08, 1.14) 1.10 (1.07, 1.12) 1.08 (1.04, 1.11)
Age 1.12 (1.09, 1.14) 1.11 (1.09, 1.13) 1.12 (1.09, 1.14) 1.11 (1.09, 1.13)
Years of education 1.02 (0.99, 1.05)* 1.04 (1.01, 1.07) 1.05 (1.02, 1.08) 1.04 (1.00, 1.07)*
Frailty 1.73 (1.57, 1.92) 1.71 (1.54, 1.89)
Social vulnerability 1.21 (1.13, 1.29) 1.13 (1.05, 1.21)
Protective Factors 0.79 (0.73, 0.86) 0.81 (0.74, 0.89)
Model fit statistics
−2log likelihood 3,031.24 3,333.43 3,168.75 2,980.07
Values are shown as odds ratios (95% confidence intervals) except for –2log likelihood. *Not significant at P = 0.05 level.
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While research that focuses on individual protective fac-
tors is undoubtedly important, it is also necessary to de-
velop understanding of how these factors work in
combination with each other to protect against cognitive
decline in old age.
Frailty was a significant predictor of cognitive states at
3 and 6 years from baseline. Recent studies have found
similar findings in other cohort studies using the FI
[14,15] as well as the Fried phenotypic approach to
measuring frailty [41-46]. The findings of the current
study extend this body of literature by examining cogni-
tive change and frailty across multiple time points in a
cohort while controlling for important confounders and
accounting for attrition due to mortality. At present,
even though the mechanisms underlying the relationship
between frailty and cognitive decline are not clear, some
clues about brain health are emerging. For example,
Buchman and colleagues found that the rate of progres-
sion of frailty was significantly associated with the pres-
ence of macroinfarcts, Alzheimer's disease and Lewy body
pathology, and nigral neuronal loss [47]. When considered
together in a single model, the neuropathology in the
study explained 8% of the variance in the rate of progres-
sion of frailty, after accounting for demographic variables.
The results of the transition models also illustrated the
cumulative effect of social factors on both cognitive
decline and mortality. When considered in relation toage and education, the accumulation of social deficits
was significantly associated with cognitive decline at
wave 2 and death by wave 3. The results coincide with
recent research that indicated the importance of examin-
ing multiple social factors in parallel. Shankar and col-
leagues found significant interaction effects of isolation
and loneliness, indicating the need to study the effects of
these social factors simultaneously [48]. Here, we have
compiled a series of social factors and found that an
accumulation of social deficits is predictive of future
cognitive transitions, warranting further research atten-
tion to potential interventions that may lessen the
burden of social vulnerability in older adults. While feel-
ings of loneliness have been shown to predict the onset
of dementia in community-living older persons [49],
more work is required to further understand how exter-
nal factors can accumulate and synergistically impact
health outcomes.
For transitions in cognition across both intervals, on
average, education had protective effect. This reflects the
well-known relationship between education and cogni-
tive status in late life, in which more education is associ-
ated with better cognitive outcomes. However, results
with respect to the impact of education on the trajectory
of age-related cognitive decline have been mixed [50].
The results of this study add to this debate, and illustrate
that, on average, increases in education are associated
with better cognitive outcomes over 3 and 6 years, even
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accumulation of protective factors. Due to the complex
relationships between education, health states, and global
cognition in older adults, more research is needed to
disentangle their relationships to develop a more robust
understanding of how they interact to impact well-
being. From the logistic models, education was not
associated with risk of death after accounting for the
other covariates. This lack of an effect is likely due to
stronger influences of age, baseline cognitive state, and
the index variables on mortality.
Our results must be interpreted with caution. Even
though the HAAS death data are nearly complete, missing
data including men too ill to participate may have im-
pacted the estimates of the models. Second, the study
used self-report data, which can be less accurate than
data retrieved clinically or through laboratory tests and
can be influenced by the cognitive state of the subjects.
The FI was constructed using 48 items that were not
strongly correlated with cognitive decline. Despite this
careful approach, the FI still contained some variables
that have previously been associated with risk of
dementia or cognitive decline, so their combined effect
on worsening cognition is not surprising. What this
adds is an estimate of their combined effect, showing
that risks for cognitive decline in late life need to take
into account the overall degree of health [51]. Further,
previous research has shown that frailty, measured in
different ways, including a set of non-traditional risk
factors for dementia [52,53], can be associated with
future cognitive states. Even so, that work has been
criticized for not being closely enough tied to causal
mechanisms, thereby limiting applicability in under-
standing how particular interventions might work. The
current report addresses this in two ways: first, it shows
the type of factors, in the PI, that can mitigate risk.
Second, it illustrates how the deficit accumulation
approach can be employed to take into account a
broader range of risk factors than often gets considered
in single risk factor models. For example, if new risk
factor X or novel protective factor Y were to be
proposed, the importance of their impact would be
enhanced if it withstood adjustment for the types of
index variables proposed here.
Both the SVI and the PI might have benefitted had
additional factors that were not measured in the baseline
wave of the HAAS been included. Nevertheless, the
effects of both these indices were significantly associated
with the health outcomes at multiple time points. The
optimization of these indices warrants further investi-
gation and is of interest to our research group. By
conducting transformations on the original CASI scores,
cognitive states were arbitrarily defined using groupings
of three. This type of transformation is computationallyconvenient and is unlikely to mix clinically separable
states. Even so, to ensure that choice of grouping did not
influence the results, models were also developed using
alternative groupings (2, 4, 5); these led to similar re-
sults. Finally, these analyses only evaluated the impact of
baseline measurements with future health outcomes. It
is important to realize that these baseline factors also
operate in a dynamic way and will also change consider-
ably over the years. Future analyses examining cognitive
changes in late life should also aim to consider factors
such as frailty and social vulnerability as time-varying
covariates. This type of approach would greatly assist in
developing our understanding of the complex dynamics
in late life.
Conclusions
In the HAAS cohort, as in others, average cognitive func-
tion declines over time. When taking a traditional statis-
tical approach, improvement and stability can get lost in
this average decline. In contrast, the transition modeling
approach that we have employed not only accounts for
cognitive dynamics, but also may allow some insights
into the phenomenon of late-life cognitive decline that
is certainly becoming a major issue for public health.
Coupled with the use of index variables, it appears to
allow a critical perspective in adjudicating claims about
individual risk factors. As a recent Nature commentary
pointed out, it is essential that we employ approaches
that take into account the heterogeneity of disease risk
and expression in evaluating age-associated illness [54].
These considerations are motivating additional inquiries
by our group.
Additional file
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